Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.1. Removed the notice about lapse in government funding and the prior Revision: v3.4.0.SummaryDifference0.1%

- Check51 days agoChange DetectedA top-of-page notice informs users about a lapse in government funding and possible processing delays, and directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a glossary toggle and new metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, plus a new Revision: v3.4.0. Older items were removed or renamed, including Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.